NATIXIS

Position in TECH — BIO-TECHNE Corp

CIK 1274981 PARIS, I0

Position in TECH

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$589,806

-$4,224,080 QoQ

Shares Held

11,286

-87.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIXIS holds $79,787,364 across 30 Biotechnology names. TECH ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	55,307	$42,732,400
2	VRTX	Vertex Pharmaceuticals Inc / Ma	48,192	$21,519,655
3	ALNY	Alnylam Pharmaceuticals, Inc.	17,076	$5,649,936
4	ERAS	Erasca, Inc.	163,192	$2,640,446
5	RARE	Ultragenyx Pharmaceutical Inc.	81,754	$1,712,746
6	COGT	Cogent Biosciences, Inc.	41,536	$1,598,720
7	CAI	Caris Life Sciences, Inc.	52,778	$943,670
8	TECH	BIO-TECHNE Corp This page	11,286	$589,806

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$589,806	11,286	-87.0%	Shares	Sole	2026-05-14
2025-09-30	$4,813,886	86,534	+246.3%	Shares	Sole	2025-11-14
2025-06-30	$1,285,786	24,991	+82.6%	Shares	Sole	2025-08-13
2025-03-31	$802,351	13,685	+31.4%	Shares	Sole	2025-07-18
2024-12-31	$749,976	10,412	-29.6%	Shares	Sole	2025-02-13
2024-06-30	$1,059,631	14,789	-12.1%	Shares	Sole	2024-08-13
2023-12-31	$1,298,062	16,823	+1362.9%	Shares	Sole	2024-02-13
2022-12-31	$95,312	1,150	-69.3%	Shares	Sole	2023-02-24
2022-09-30	$265,895	3,745	+23.8%	Shares	Sole	2022-11-14
2022-06-30	$262,059	3,024	+178.2%	Shares	Sole	2022-08-12
2021-09-30	$131,681	1,087	+36.9%	Shares	Sole	2021-11-12
2021-06-30	$89,376	794	-85.8%	Shares	Sole	2021-08-13
2021-03-31	$534,702	5,600	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.